Business

Director Dealing

Director Dealing.

articleSareum Holdings PlcSeptember 5, 20235/company/sareum-hldgs-plc/news/director-dealing-31
Director Dealing

About this update from Sareum Holdings Plc

[{"type":"text","content":"\n\nSareum Holdings PLC\n(\"Sareum\" or the \"Company\")\nDirector Dealing\nCambridge, UK, 05 September 2023 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer, announces that Mr Clive Birch, Non-Executive Director, purchased 4,630 ordinary shares of 0.0125 pence each in the Company (\"Ordinary Shares\") at an average price of 82.71 pence per share on 4 September 2023.\nFollowing the transaction, Mr Clive Birch has a holding in Sareum of 44,597 Ordinary Shares, representing approximately 0.06% of Sareum's current issued share capital.\nThe notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further details.\nPDMR Notification Form:\n\n\n\n1\n\n\nDetails of the person discharging managerial responsibilities/person closely associated\n \n\n\n\n\na)   \n\n\nName\n\n\nClive Birch\n\n\n\n\n2\n\n\nReason for the notification\n\n\n\n\na)   \n\n\nPosition/status\n\n\nNon-Executive Director\n\n\n\n\nb)   \n\n\nInitial notification/amendment\n\n\nInitial notification\n\n\n\n\n3\n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\na)   \n\n\nName\n\n\nSareum Holdings plc\n\n\n\n\nb)   \n\n\nLEI\n\n\n213800PKERN2DY8FFM72\n\n\n\n\n4\n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)   \n\n\nDescription of the financial instrument, type of instrument\n\n\nOrdinary shares of 0.0125 pence each in the share capital of Sareum Holdings plc\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nIdentification code\n\n\nGB00B02RFS12\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nb)   \n\n\nNature of the transaction\n\n\nPurchase of shares\n\n\n\n\nc)   \n\n\nPrice(s) and volume(s)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPrice(s)\n\n\nVolume(s)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n£0.8322\n\n\n2,151\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n£0.8227\n\n\n2,479\n\n\n\n\n\n\n\nd)   \n\n\nAggregated information\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n-  &n...

More updates from Sareum Holdings Plc